Literature DB >> 36138136

JAK inhibition shows two faces in prostate cancer.

Nicholas J Brady1, Christopher E Barbieri2,3,4.   

Abstract

Entities:  

Year:  2022        PMID： 36138136     DOI： 10.1038/s43018-022-00437-3

Source DB:  PubMed          Journal:  Nat Cancer        ISSN： 2662-1347


× No keyword cloud information.
  1 in total

1.  Ectopic JAK-STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance.

Authors:  Su Deng; Choushi Wang; Yunguan Wang; Yaru Xu; Xiaoling Li; Nickolas A Johnson; Atreyi Mukherji; U-Ging Lo; Lingfan Xu; Julisa Gonzalez; Lauren A Metang; Jianfeng Ye; Carla Rodriguez Tirado; Kathia Rodarte; Yinglu Zhou; Zhiqun Xie; Carlos Arana; Valli Annamalai; Xihui Liu; Donald J Vander Griend; Douglas Strand; Jer-Tsong Hsieh; Bo Li; Ganesh Raj; Tao Wang; Ping Mu
Journal:  Nat Cancer       Date:  2022-09-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.